Moreover, the authors demonstrated the APL-like phenotype beneficially impacted RFS and OS, and its combination with coexisting TET2 or IDH1/2 mutations was more explicit to refine prognostic subgroups. Here, IDH1 is linked to acute promyelocytic leukemia.